- Home
- CLLS vs SKYX Comparison
CLLS vs SKYX Comparison
Compare CLLS & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- SKYX
- Stock Information
- Founded
- CLLS 1999
- SKYX 2004
- Country
- CLLS France
- SKYX United States
- Employees
- CLLS N/A
- SKYX N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- SKYX Building Products
- Sector
- CLLS Health Care
- SKYX Consumer Discretionary
- Exchange
- CLLS Nasdaq
- SKYX Nasdaq
- Market Cap
- CLLS 144.4M
- SKYX 99.2M
- IPO Year
- CLLS 2007
- SKYX 2022
- Fundamental
- Price
- CLLS $1.53
- SKYX $1.34
- Analyst Decision
- CLLS Buy
- SKYX Strong Buy
- Analyst Count
- CLLS 3
- SKYX 2
- Target Price
- CLLS $7.00
- SKYX $3.50
- AVG Volume (30 Days)
- CLLS 84.6K
- SKYX 310.3K
- Earning Date
- CLLS 05-27-2025
- SKYX 05-16-2025
- Dividend Yield
- CLLS N/A
- SKYX N/A
- EPS Growth
- CLLS N/A
- SKYX N/A
- EPS
- CLLS N/A
- SKYX N/A
- Revenue
- CLLS $49,217,000.00
- SKYX $86,276,876.00
- Revenue This Year
- CLLS $48.52
- SKYX $23.10
- Revenue Next Year
- CLLS $5.17
- SKYX $27.44
- P/E Ratio
- CLLS N/A
- SKYX N/A
- Revenue Growth
- CLLS 435.38
- SKYX 46.77
- 52 Week Low
- CLLS $1.10
- SKYX $0.75
- 52 Week High
- CLLS $3.32
- SKYX $2.14
- Technical
- Relative Strength Index (RSI)
- CLLS 56.17
- SKYX 60.02
- Support Level
- CLLS $1.54
- SKYX $1.23
- Resistance Level
- CLLS $1.65
- SKYX $1.43
- Average True Range (ATR)
- CLLS 0.08
- SKYX 0.11
- MACD
- CLLS -0.00
- SKYX 0.03
- Stochastic Oscillator
- CLLS 58.62
- SKYX 79.07
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About SKYX SKYX Platforms Corp.
SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.